Ziying Lei

1.9k total citations
39 papers, 1.3k citations indexed

About

Ziying Lei is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ziying Lei has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Hepatology and 8 papers in Surgery. Recurrent topics in Ziying Lei's work include Intraperitoneal and Appendiceal Malignancies (7 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ziying Lei is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (7 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ziying Lei collaborates with scholars based in China, United States and United Kingdom. Ziying Lei's co-authors include Liang Peng, Zhanlian Huang, Wenxiong Xu, Dabiao Chen, Shuzhong Cui, Quanxing Liao, Qingjun He, Zhiliang Gao, Xianzi Yang and Lisi Zeng and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Stem Cells.

In The Last Decade

Ziying Lei

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziying Lei China 14 513 412 328 156 153 39 1.3k
Junli Fan China 12 711 1.4× 227 0.6× 142 0.4× 228 1.5× 85 0.6× 20 1.5k
Wegene Borena Austria 19 299 0.6× 360 0.9× 455 1.4× 284 1.8× 422 2.8× 61 1.4k
Daniëlle Cohen Netherlands 24 362 0.7× 151 0.4× 144 0.4× 197 1.3× 261 1.7× 54 1.9k
Alessandro Pellegrinelli Italy 16 891 1.7× 209 0.5× 132 0.4× 313 2.0× 381 2.5× 28 1.9k
Juan Manuel Mejía‐Aranguré Mexico 21 160 0.3× 217 0.5× 133 0.4× 84 0.5× 472 3.1× 106 1.5k
Chung Ying Leung China 7 676 1.3× 175 0.4× 85 0.3× 30 0.2× 168 1.1× 11 1.1k
Lan Yang China 12 819 1.6× 199 0.5× 62 0.2× 95 0.6× 111 0.7× 22 1.3k
Shaohang Cai China 20 146 0.3× 244 0.6× 208 0.6× 108 0.7× 496 3.2× 63 1.0k
Antonio Russo Italy 17 136 0.3× 168 0.4× 113 0.3× 269 1.7× 228 1.5× 64 1.0k

Countries citing papers authored by Ziying Lei

Since Specialization
Citations

This map shows the geographic impact of Ziying Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziying Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziying Lei more than expected).

Fields of papers citing papers by Ziying Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziying Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziying Lei. The network helps show where Ziying Lei may publish in the future.

Co-authorship network of co-authors of Ziying Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Ziying Lei. A scholar is included among the top collaborators of Ziying Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziying Lei. Ziying Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Ziying, Yue Wang, Jiali Luo, et al.. (2025). Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow‐up of long‐term survival. Acta Obstetricia Et Gynecologica Scandinavica. 104(5). 988–997. 1 indexed citations
2.
Xia, Xiaohong, et al.. (2025). The deubiquitinase USP7 stabilizes HER2 expression and promotes breast cancer progression. Neoplasia. 66. 101192–101192.
4.
Wang, Peipei, Ying Zhang, Dabiao Chen, et al.. (2023). Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon. Frontiers in Immunology. 13. 1104329–1104329. 4 indexed citations
5.
Zheng, Jiaxin, Xiaojie Li, Ziying Lei, et al.. (2022). Colonization with Carbapenem-Resistant Enterobacteriaceae Contributes to Unfavorable Outcomes in End-Stage Liver Disease Patients. Antibiotics. 11(11). 1667–1667. 1 indexed citations
6.
Yao, Leyi, Qian Zhao, Yan Ding, et al.. (2022). Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells. Cancer Biology and Medicine. 19(7). 1061–1077. 7 indexed citations
7.
Zeng, Lisi, Xubo Huang, Yun Tian, et al.. (2022). Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy. Frontiers in Oncology. 12. 796263–796263. 2 indexed citations
8.
Chen, Junfeng, Ziying Lei, Huijuan Cao, et al.. (2022). Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology International. 16(4). 775–788. 5 indexed citations
9.
Wang, Xiaoyun, et al.. (2022). Spinal canal infection caused by Streptococcus suis in human: a case report. BMC Infectious Diseases. 22(1). 369–369. 3 indexed citations
10.
Chen, Zhaoming, Zhengtu Li, Wei‐jie Guan, et al.. (2022). Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with Talaromyces marneffei Infections. Infection and Drug Resistance. Volume 15. 3381–3393. 8 indexed citations
11.
Liu, Jing, Ziying Lei, Jianyun Zhu, et al.. (2021). Rapid diagnosis of disseminated Mycobacterium mucogenicum infection in formalin-fixed, paraffin-embedded specimen using next-generation sequencing: A case report. World Journal of Clinical Cases. 9(20). 5621–5630. 1 indexed citations
12.
Liu, Jing, Sheng Liu, Zhao Zhang, et al.. (2021). Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19. Synthetic and Systems Biotechnology. 6(3). 135–143. 35 indexed citations
13.
Lei, Ziying, et al.. (2021). Hepatotoxicity of iodine-131 ablation for post-surgical differentiated thyroid cancer patients with hepatitis B virus infection. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101631–101631. 1 indexed citations
14.
Chen, Dabiao, Wenxiong Xu, Ziying Lei, et al.. (2020). Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report. International Journal of Infectious Diseases. 93. 297–299. 242 indexed citations
15.
Zeng, Lisi, Quanxing Liao, Zhaowei Zou, et al.. (2018). Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Cellular Physiology and Biochemistry. 51(3). 1221–1236. 49 indexed citations
16.
Li, Xinhua, Jing Huang, Hong Deng, et al.. (2018). IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation. BMC Gastroenterology. 18(1). 61–61. 15 indexed citations
17.
Yang, Xianzi, Qingjun He, Tiantian Cheng, et al.. (2018). Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma. Cellular Physiology and Biochemistry. 48(1). 251–262. 20 indexed citations
18.
Yang, Xianzi, Tiantian Cheng, Qingjun He, et al.. (2018). LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Molecular Cancer. 17(1). 126–126. 310 indexed citations
19.
Lei, Ziying, Jianyun Zhu, Ke Wang, et al.. (2015). Soluble ST2 Plasma Concentrations Predict Mortality in HBV‐Related Acute‐on‐Chronic Liver Failure. Mediators of Inflammation. 2015(1). 535938–535938. 19 indexed citations
20.
Zheng, Yubao, Dong‐Ying Xie, Liang Peng, et al.. (2012). A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort study. Hepatology International. 6(4). 727–734. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026